Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
PEP-Therapy
company
About
Innovative peptides as targeted therapies for oncology
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- €1.60M
- Industries
- Biotechnology,Medical,Therapeutics
- Founded date
- Jan 2, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
PEP-Therapy is a biotechnology company developing first-in-class peptides as targeted therapies for severe diseases, with an initial focus on cancer. PEP-Therapy develops Cell Penetrating and Interfering Peptides (CP&IP) for the intracellular delivery of targeted therapies. These active compounds penetrate cells and block relevant intracellular protein-protein interactions, thus inhibiting key pathological mechanisms.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
€4.35M
PEP-Therapy has raised a total of
€4.35M
in funding over 2 rounds. Their latest funding was raised on
Jul 19, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 19, 2021 | Series A | €1.60M | 2 | — | — | Detail |
| Apr 22, 2021 | Series A | €2.75M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
PEP-Therapy is funded by 2 investors.
i&i Prague
and Business Angels des Grandes Ecoles
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
Business Angels des Grandes Ecoles
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
